{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:27:21Z","timestamp":1772782041278,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Publishing Company","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neonatal Network"],"published-print":{"date-parts":[[1999,4]]},"abstract":"<jats:p>DIURETICS ARE COMMONLY USED IN the neonatal intensive care unit (NICU) to remove excess extracellular fluid secondary to various diseases, such as chronic lung disease (CLD) and congestive heart failure (CHF). Diuretics are among the most used of all medications across age groups. They are also among the most abused medications, with the potential for many untoward side effects.<jats:sup>3,4<\/jats:sup>Thus, NICU nurses must understand their appropriate use, their possible consequences, and the monitoring required when using them. Furosemide and chlorothiazide have been reviewed previously (<jats:italic>see Neonatal Network<\/jats:italic>, 1991, 9(7): 65\u201367, and 1993, 12(7): 69\u201370, respectively). This column focuses on spironolactone use.<\/jats:p>","DOI":"10.1891\/0730-0832.18.3.43","type":"journal-article","created":{"date-parts":[[2012,5,8]],"date-time":"2012-05-08T07:42:12Z","timestamp":1336462932000},"page":"43-46","source":"Crossref","is-referenced-by-count":1,"title":["Spironolactone"],"prefix":"10.1891","volume":"18","author":[{"given":"Barbara","family":"Noerr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"793","published-online":{"date-parts":[[1999,4,1]]},"reference":[{"key":"1","first-page":"678","volume-title":"Pediatric Dosage Handbook","volume":"4th","author":"C Taketomo","year":"1997"},{"key":"2","first-page":"139","volume-title":"Neofax '97: A Manual of Drugs Used Neonatal Care","author":"T Young","year":"1997"},{"key":"3","first-page":"524","article-title":"Diuretics","volume-title":"Pediatric Pharmacology: Therapeutic Principles in Practice","author":"J Sherbotie","year":"1992"},{"key":"4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0065-3101(24)00015-X","article-title":"Diuretic treatment agents.","volume":"40","author":"M. Bailie","year":"1993","journal-title":"Advances in Pediatrics"},{"key":"5","first-page":"620","article-title":"Assessment and management of genitourinary dysfunction","volume-title":"Comprehensive Neonatal Nursing: A Physiologic Perspective","author":"C. Kenner","year":"1998"},{"issue":"5","key":"6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/00325481.1993.11701670","article-title":"Role of aldosterone in congestive heart failure","volume":"93","author":"K Weber","year":"1993","journal-title":"Postgraduate Medicine"},{"issue":"3","key":"7","doi-asserted-by":"crossref","DOI":"10.1016\/0002-9149(93)90244-7","article-title":"Dose-related cardiovascular effects of spironolactone","volume":"71","author":"D Schohn","year":"1993","journal-title":"American Journal of Cardiology"},{"issue":"2","key":"8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0029-6465(22)02302-7","article-title":"Current management of congestive heart failure in infants and children","volume":"30","author":"L Kohr","year":"1995","journal-title":"Nursing Clinics of North America"},{"key":"9","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0022-3476(05)81373-3","article-title":"Randomized trial of long-term diuretic therapy for infants with oxygen-dependent bronchopulmonary dysplasia","volume":"124","author":"L Kao","year":"1994","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/106002809502900220","article-title":"Acidosis and extreme hyperkalemia associated with cholestyramine and spironolactone","volume":"29","author":"P Zapater","year":"1995","journal-title":"Annals of Pharmacotherapy"},{"issue":"5","key":"11","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1177\/106002809703100511","article-title":"Spironolactone-induced agranulocytosis","volume":"31","author":"A Whitling","year":"1997","journal-title":"Annals of Pharmacotherapy"}],"container-title":["Neonatal Network"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1891\/0730-0832.18.3.43","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T09:27:56Z","timestamp":1713950876000},"score":1,"resource":{"primary":{"URL":"http:\/\/connect.springerpub.com\/lookup\/doi\/10.1891\/0730-0832.18.3.43"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,4]]},"references-count":11,"journal-issue":{"issue":"3","published-online":{"date-parts":[[1999,4,1]]},"published-print":{"date-parts":[[1999,4]]}},"alternative-id":["10.1891\/0730-0832.18.3.43"],"URL":"https:\/\/doi.org\/10.1891\/0730-0832.18.3.43","relation":{},"ISSN":["0730-0832","1539-2880"],"issn-type":[{"value":"0730-0832","type":"print"},{"value":"1539-2880","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,4]]}}}